Phage Therapies Targeting Pathogenic Bacteria in Chronic Indications

Time: 1:00 pm
day: Day Two – Track A – 1

Details:

  • BOLT – a novel phage discovery platform allowing clinical data within 12-18 months
  • Cystic fibrosis – A phase 1b/2a study of BX004 targeting P. Aeruginosa
  • Atopic dermatitis – BX005, a topical phage cocktail targeting S. Aureus

Speakers: